Atea Pharmaceuticals has already laid off a quarter of its workforce so far this year as the biotech prepares to launch a phase 3 trial of its hepatitis C co-ktail.
https://www.fiercebiotech.com/biotech/atea-offloads-quarter-its-workforce-while-gearing-phase-3-hcv-trials